CME Group Inc. Reports Second-Quarter 2020 Financial Results

Rhea-AI Summary

CME Group reported strong financial results for Q2 2020, with revenue of $1.2 billion and net income of $503 million, translating to diluted earnings per share of $1.40. On an adjusted basis, net income was $583 million, with diluted EPS of $1.63. The Average Daily Volume (ADV) was 17.6 million contracts, with clearing and transaction fees revenue reaching $940.2 million. The company has returned approximately $13.8 billion to shareholders since 2012. CME Group's commitment to innovation continues as they prepare to launch new products, including options on Micro E-mini Equity futures.

Positive

• Q2 2020 revenue of $1.2 billion.
• Net income of $503 million, adjusted net income of $583 million.
• Diluted EPS of $1.40, adjusted diluted EPS of $1.63.
• Average Daily Volume of 17.6 million contracts.
• Clearing and transaction fees revenue of $940.2 million.
• Returned approximately $13.8 billion to shareholders since 2012.

Negative

• None.

CHICAGO, July 29, 2020 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2020.

The company reported revenue of $1.2 billion and operating income of $638 million for the second quarter of 2020.  Net income was $503 million and diluted earnings per share were $1.40.  On an adjusted basis, net income was $583 million and diluted earnings per share were $1.63.  Financial results presented on an adjusted basis for the second quarter of 2020 and 2019 exclude certain items, which are detailed in the reconciliation of non-GAAP results.¹

"Despite the difficult circumstances the coronavirus pandemic has caused around the world, our markets have continued to help clients manage their risk and navigate uncertainty," said CME Group Chairman and Chief Executive Officer Terry Duffy.  "I am extremely proud of the way our employees have ensured the resiliency of our systems and effective operations of our markets while working from home.  During this time, we have continued to deliver innovative new products, including the reintroduction of our 3-Year Treasury Note futures earlier this month, as well as new options on our highly successful Micro E-mini Equity futures that will begin trading in August.  We also remain focused on the increased value we will provide to market participants through the migration of our BrokerTec business to CME Globex in Q4.  As we look ahead, we remain committed to promoting the safety of our employees while continuing to facilitate the risk transfer and price discovery needed to help business and economies everywhere recover from this crisis."

Second-quarter 2020 ADV was 17.6 million contracts, including non-U.S. ADV of 4.9 million contracts. 

1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.

Clearing and transaction fees revenue for second-quarter 2020 totaled $940.2 million. The total average rate per contract was $0.731.  Market data revenue totaled $134.7 million for second-quarter 2020.

As of June 30, 2020, the company had approximately $1.5 billion in cash (including $125 million deposited with Fixed Income Clearing Corporation (FICC) and included in other current assets) and $3.4 billion of debt.  The company paid dividends during the second quarter of $304 million.  The company has returned approximately $13.8 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.

CME Group will hold a Q&A conference call to discuss Second-quarter 2020 results at 8:30 a.m. Eastern Time today.  A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at www.cmegroup.com.  An archived recording will be available for up to two months after the call.

As the world's leading and most diverse derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data - empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals.  The company offers futures and options on futures trading through the CME Globex® platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. With a range of pre- and post-trade products and services underpinning the entire lifecycle of a trade, CME Group also offers optimization and reconciliation services through TriOptima, and trade processing services through Traiana.

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc.  CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc. BrokerTec, EBS, TriOptima, and Traiana are trademarks of BrokerTec Europe LTD, EBS Group LTD, TriOptima AB, and Traiana, Inc., respectively. Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc.  All other trademarks are the property of their respective owners. 

Statements in this press release that are not historical facts are forward-looking statements.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services, including our ability to provide effective services to the swaps market; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policy with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management methods to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk through third-parties, including risks related to the performance, reliability and security of technology used by our third-party providers; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, credit spreads, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; the impact of the (COVID-19) pandemic and response by governments and other third parties; our ability to accommodate increases in contract volume and order transaction traffic and to implement enhancements without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated with the acquisition of NEX; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry and customer consolidation; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options on futures transactions and/or repeal of the 60/40 tax treatment of such transactions; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings.  For a detailed discussion of these and other factors that might affect our performance, see our filings with the Securities and Exchange Commission, including our most recent periodic reports filed on Form 10-K and Form 10-Q.

 

CME Group Inc. and Subsidiaries
Consolidated Balance Sheets
(in millions)
		June 30, 2020				December 31, 2019
ASSETS
Current Assets:
Cash and cash equivalents		$	1,405.4			$	1,551.4
Marketable securities		88.1				83.2
Accounts receivable, net of allowance		532.1				491.8
Other current assets (includes $4.4 and $4.3 in restricted cash)		319.2				364.4
Performance bonds and guaranty fund contributions		79,441.4				37,077.0
Total current assets		81,786.2				39,567.8
Property, net of accumulated depreciation and amortization		538.6				544.0
Intangible assets—trading products		17,175.3				17,175.3
Intangible assets—other, net		4,931.7				5,117.7
Goodwill		10,742.5				10,742.5
Other assets (includes $0.7 and $0.9 in restricted cash)		2,040.5				2,068.0
Total Assets		$	117,214.8			$	75,215.3
LIABILITIES AND EQUITY
Current Liabilities:
Accounts payable		$	88.0			$	61.9
Other current liabilities		672.5				1,384.8
Performance bonds and guaranty fund contributions		79,440.9				37,075.8
Total current liabilities		80,201.4				38,522.5
Long-term debt		3,440.9				3,743.2
Deferred income tax liabilities, net		5,607.3				5,635.2
Other liabilities		1,126.3				1,155.1
Total Liabilities		90,375.9				49,056.0
CME Group Shareholders' Equity		26,807.9				26,128.9
Non-controlling interests		31.0				30.4
Total Equity		26,838.9				26,159.3
Total Liabilities and Equity		$	117,214.8			$	75,215.3

 

CME Group Inc. and Subsidiaries
Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
		Quarter Ended June 30,								Six Month Ended, June 30,
		2020				2019				2020				2019
Revenues
Clearing and transaction fees		$	940.2			$	1,051.8			$	2,219.0			$	2,004.4
Market data and information services		134.7				128.3				266.2				258.4
Other		107.4				92.6				219.2				189.5
Total Revenues		1,182.3				1,272.7				2,704.4				2,452.3
Expenses
Compensation and benefits		217.0				227.3				424.5				457.6
Technology		49.1				48.6				96.8				95.7
Professional fees and outside services		51.2				41.7				92.9				81.1
Amortization of purchased intangibles		76.6				76.1				153.9				156.8
Depreciation and amortization		36.7				46.3				72.0				79.2
Licensing and other fee agreements		55.4				44.8				129.3				85.3
Other		58.8				89.3				137.6				167.0
Total Expenses		544.8				574.1				1,107.0				1,122.7
Operating Income		637.5				698.6				1,597.4				1,329.6
Non-Operating Income (Expense)
Investment income		32.1				139.3				128.0				318.0
Interest and other borrowing costs		(41.9)				(45.1)				(82.8)				(93.2)
Equity in net earnings (losses) of unconsolidated subsidiaries		48.8				43.8				100.0				84.3
Other non-operating income (expense)		(15.2)				(134.5)				(92.0)				(296.4)
Total Non-Operating Income (Expense)		23.8				3.5				53.2				12.7
Income before Income Taxes		661.3				702.1				1,650.6				1,342.3
Income tax provision		158.0				187.5				380.5				331.8
Net Income		503.3				514.6				1,270.1				1,010.5
Less: net (income) loss attributable to non-controlling interests		—				(0.8)				(0.6)				0.2
Net Income Attributable to CME Group		$	503.3			$	513.8			$	1,269.5			$	1,010.7
Earnings per Common Share Attributable to CME Group:
Basic		$	1.41			$	1.44			$	3.55			$	2.83
Diluted		1.40				1.43				3.54				2.82
Weighted Average Number of Common Shares:
Basic		357,691				357,060				357,607				356,973
Diluted		358,457				358,155				358,453				358,103

 

CME Group Inc. and Subsidiaries

Quarterly Operating Statistics

2Q 2019

3Q 2019

4Q 2019

1Q 2020

2Q 2020

Trading Days

63

64

64

62

63

 

Quarterly Average Daily Volume (ADV)(1)
CME Group ADV (in thousands)
Product Line		2Q 2019			3Q 2019			4Q 2019			1Q 2020			2Q 2020
Interest rates		11,593			10,868			8,638			13,813			6,890
Equity indexes		3,480			3,931			3,252			6,498			5,568
Foreign exchange		874			850			839			1,079			725
Energy		2,498			2,456			2,213			3,228			2,586
Agricultural commodities		1,839			1,320			1,278			1,506			1,311
Metals		633			821			652			889			519
Total		20,918			20,247			16,872			27,013			17,599
Venue
CME Globex		18,505			18,282			15,356			24,582			16,992
Open outcry (2)		1,501			1,177			867			1,281			—
Privately negotiated		912			788			650			1,149			607
Total		20,918			20,247			16,872			27,013			17,599

 

Quarterly Average Rate Per Contract (RPC)(1)
CME Group RPC
Product Line		2Q 2019				3Q 2019				4Q 2019				1Q 2020				2Q 2020
Interest rates		$	0.476			$	0.500			$	0.507			$	0.488			$	0.510
Equity indexes		0.676				0.612				0.654				0.616				0.574
Foreign exchange		0.713				0.720				0.732				0.721				0.786
Energy		1.139				1.137				1.133				1.108				1.191
Agricultural commodities		1.222				1.234				1.242				1.260				1.316
Metals		1.455				1.414				1.344				1.429				1.518
Average RPC		$	0.693			$	0.693			$	0.717			$	0.676			$	0.731

1. ADV and RPC includes futures and options on futures only.

2. The trading floor was temporarily closed in March 2020 in response to the stay-at-home orders. We plan a limited reopening in the third quarter.

 

CME Group Inc. and Subsidiaries
Reconciliation of GAAP to non-GAAP Measures
(dollars in millions, except per share amounts; shares in thousands)
		Quarter Ended June 30,								Six Month Ended, June 30,
		2020				2019				2020				2019
Net Income Attributable to CME Group		$	503.3			$	513.8			$	1,269.5			$	1,010.7
Restructuring and severance		4.7				7.0				10.6				10.3
Amortization of purchased intangibles		76.6				76.1				153.9				156.8
Acquisition-related costs(1)		9.1				6.6				17.2				14.5
Foreign exchange transaction (gains) losses(2)		(0.1)				(5.2)				(3.7)				2.4
Unrealized and realized (gains) losses on investments		5.4				23.3				2.5				26.7
Loss on real estate sublease and related costs		—				5.0				—				5.4
(Gains) losses on derivatives		—				2.3				(1.5)				16.7
Realized and unrealized (gains) losses on assets(3)		3.5				32.2				26.1				32.2
Litigation matters		4.0				—				4.0				—
Trading floor enhancements		1.0				—				1.0				—
Income tax effect related to above		(23.3)				(29.5)				(59.6)				(57.3)
Other income tax items		(1.0)				—				(1.0)				(7.6)
Adjusted Net Income Attributable to CME Group		$	583.2			$	631.6			$	1,419.0			$	1,210.8
GAAP Earnings per Common Share Attributable to CME Group:
Basic		$	1.41			$	1.44			$	3.55			$	2.83
Diluted		1.40				1.43				3.54				2.82
Adjusted Earnings per Common Share Attributable to CME Group:
Basic		$	1.63			$	1.77			$	3.97			$	3.39
Diluted		1.63				1.76				3.96				3.38
Weighted Average Number of Common Shares:
Basic		357,691				357,060				357,607				356,973
Diluted		358,457				358,155				358,453				358,103

1. Acquisition-related costs primarily include professional fees related to the NEX transaction.

2. Results include foreign exchange transaction net gains and losses principally related to cash held in British pounds within entities whose functional currency is the U.S. dollar.

3. Results include net gains and losses on intangible assets, fixed assets and assets held for sale.

CME-G

View original content:http://www.prnewswire.com/news-releases/cme-group-inc-reports-second-quarter-2020-financial-results-301101788.html

SOURCE CME Group

FAQ

What were CME Group's financial results for Q2 2020?

CME Group reported revenue of $1.2 billion and net income of $503 million for Q2 2020.

What is CME Group's diluted earnings per share for Q2 2020?

CME Group's diluted earnings per share for Q2 2020 were $1.40.

What was CME Group's average daily volume in Q2 2020?

CME Group had an average daily volume of 17.6 million contracts in Q2 2020.

How has CME Group supported shareholders during the pandemic?

CME Group has returned approximately $13.8 billion to shareholders through dividends since 2012.

What new products is CME Group launching?

CME Group is launching options on Micro E-mini Equity futures and has reintroduced 3-Year Treasury Note futures.